{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:22:40Z","timestamp":1766514160557,"version":"3.44.0"},"reference-count":11,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,6,12]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>Treatment for ulcerative colitis often requires the administration of immunosuppressive therapy. Shortly after rescue therapy with infliximab for acute severe colitis, a patient who was also taking corticosteroids, azathioprine and adalimumab became rapidly unwell with atypical pneumonia, which did not respond to conventional antimicrobials. Re-examining the travel history revealed a prior caving trip to Costa Rica. Dimorphic fungal serology was thus tested and a diagnosis of paracoccidioidomycosis was made. After a lengthy intensive care unit admission, the patient made a recovery after the administration of appropriate antifungal therapy and was discharged home on long-term oral antifungals.<\/jats:p>","DOI":"10.1136\/bcr-2019-234125","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T01:55:14Z","timestamp":1593741314000},"page":"e234125","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["First report of paracoccidioidomycosis reactivation as a complication of immunosuppressive therapy for acute severe colitis in a caving enthusiast"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9156-2572","authenticated-orcid":false,"given":"Scott","family":"Healey","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Weston Area Health NHS Trust, Weston-super-Mare, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waseem","family":"Said","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Weston Area Health NHS Trust, Weston-super-Mare, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Fayyaz","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Weston Area Health NHS Trust, Weston-super-Mare, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1581-2736","authenticated-orcid":false,"given":"Andrew","family":"Bell","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Weston Area Health NHS Trust, Weston-super-Mare, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"2025082708505008000_13.7.e234125.1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof3010001","article-title":"New trends in paracoccidioidomycosis epidemiology","volume":"3","author":"Martinez","year":"2017","journal-title":"J Fungi"},{"key":"2025082708505008000_13.7.e234125.2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1590\/0037-8682-0222-2017","article-title":"Pulmonary paracoccidioidomycosis: a case report of reactivation in a patient receiving biological therapy","volume":"51","author":"Covre","year":"2018","journal-title":"Rev Soc Bras Med Trop"},{"key":"2025082708505008000_13.7.e234125.3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12281-012-0114-x","article-title":"Paracoccidioidomycosis: Latin America\u2019s Own Fungal Disorder","volume":"6","author":"Restrepo","year":"2012","journal-title":"Curr Fungal Infect Rep"},{"key":"2025082708505008000_13.7.e234125.4","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1590\/0037-8682-0230-2017","article-title":"Brazilian guidelines for the clinical management of paracoccidioidomycosis","volume":"50","author":"Shikanai-Yasuda","year":"2017","journal-title":"Rev Soc Bras Med Trop"},{"key":"2025082708505008000_13.7.e234125.5","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200969110-00002"},{"key":"2025082708505008000_13.7.e234125.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000180044.19285.9a"},{"key":"2025082708505008000_13.7.e234125.7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i43.16014"},{"key":"2025082708505008000_13.7.e234125.8","doi-asserted-by":"publisher","DOI":"10.3390\/jof5020027"},{"key":"2025082708505008000_13.7.e234125.9","doi-asserted-by":"publisher","DOI":"10.1086\/522973"},{"key":"2025082708505008000_13.7.e234125.10","doi-asserted-by":"publisher","DOI":"10.1080\/mmy.40.4.411.417"},{"key":"2025082708505008000_13.7.e234125.11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4269\/ajtmh.2009.80.359","article-title":"Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case-control study","volume":"80","author":"Morej\u00f3n","year":"2009","journal-title":"Am J Trop Med Hyg"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-234125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:50:59Z","timestamp":1756309859000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-234125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":11,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,2]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/bcr-2019-234125"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-234125","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}